Read Time:28 Second
Doha – October 22, 2025 – Denovo Sciences Inc., a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), a leading biomedical research and educational institution, and Sidra Medicine, a women’s and children’s healthcare organization, are engaging in a collaboration to identify and develop novel drug candidates for homocystinuria, a rare and genetic metabolic disorder. The partnership aims to address a significant unmet medical need, particularly in the MENA region, where the condition has one of the highest prevalence rates in the world.
Homocystinuria is an inherited disorder that impair